BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23534752)

  • 1. Clinical impact and reliability of carbonic anhydrase XII in the differentiation of malignant and tuberculous pleural effusions.
    Liu YL; Jing LL; Guo QS
    Asian Pac J Cancer Prev; 2013; 14(1):351-4. PubMed ID: 23534752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adenosine deaminase activity in tuberculous and malignant pleural effusions].
    Safianowska A; Krenke R; Dmowska-Sobstyl B; Bogacka-Zatorska E; Domagała-Kulawik J; Chazan R
    Pneumonol Alergol Pol; 2006; 74(1):5-9. PubMed ID: 17175968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions.
    Zhou WB; Bai M; Jin Y
    Int J Tuberc Lung Dis; 2009 Mar; 13(3):381-6. PubMed ID: 19275801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of carbonic anhydrase IX protein in the diagnosis of malignant pleural effusion by enzyme-linked immunosorbent assay and immunocytochemistry.
    Liao ND; Lee WY
    Cancer Cytopathol; 2012 Aug; 120(4):269-75. PubMed ID: 22367930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of detection of malignancy in pleural effusions using ELISA-based TRAP assay: comparison with cytological examination.
    Lee WY
    Cytopathology; 2005 Oct; 16(5):227-32. PubMed ID: 16181308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
    Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
    Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience.
    Loveland P; Christie M; Hammerschlag G; Irving L; Steinfort D
    Intern Med J; 2018 Nov; 48(11):1318-1324. PubMed ID: 29869427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of the detection of the homozygous deletion of P16 gene in malignant pleural effusion.
    Gui S; Liu H; Zhang L; Zuo L; Zhou Q; Fei G; Wang Y
    Intern Med; 2007; 46(15):1161-6. PubMed ID: 17675763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiology and pleural fluid characteristics of large and massive effusions.
    Porcel JM; Vives M
    Chest; 2003 Sep; 124(3):978-83. PubMed ID: 12970026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of telomerase activity between malignant and tuberculous pleural effusions.
    Maneechotesuwan K; Lertworawiwat A; Tscheikuna J; Wamanuttajinda V
    J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S46-54. PubMed ID: 17718245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.
    Tetikkurt C; Yılmaz N; Tetikkurt S; Gundogdu Ş; Disci R
    Monaldi Arch Chest Dis; 2018 Sep; 88(3):944. PubMed ID: 30203633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAXII Is a sero-diagnostic marker for lung cancer.
    Kobayashi M; Matsumoto T; Ryuge S; Yanagita K; Nagashio R; Kawakami Y; Goshima N; Jiang SX; Saegusa M; Iyoda A; Satoh Y; Masuda N; Sato Y
    PLoS One; 2012; 7(3):e33952. PubMed ID: 22439015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity in pleural effusions: diagnostic significance.
    Yang CT; Lee MH; Lan RS; Chen JK
    J Clin Oncol; 1998 Feb; 16(2):567-73. PubMed ID: 9469342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause.
    Wang XF; Wu YH; Wang MS; Wang YS
    Asian Pac J Cancer Prev; 2014; 15(1):363-8. PubMed ID: 24528057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer.
    Park KJ; Hwang SC; Sheen SS; Oh YJ; Han JH; Lee KB
    Respiration; 2005; 72(2):166-75. PubMed ID: 15824527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of carcinoembryonic antigen levels in pleural effusion and serum and their ratio for differential diagnosis of pleural effusion resulting from tuberculosis and lung cancer].
    Li R; Gao Z; Dong K; Wang H; Zhang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):175-180. PubMed ID: 30890505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pleural effusions--experience of Pneumo-phtisiology Hospital Tudor Vladimirescu--I: Clinical study].
    Olaru M; Pleşea IE; Mălăescu D; Olaru R
    Pneumologia; 2008; 57(3):138-46. PubMed ID: 18998326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive models for diagnosis of pleural effusions secondary to tuberculosis or cancer.
    Sales RK; Vargas FS; Capelozzi VL; Seiscento M; Genofre EH; Teixeira LR; Antonangelo L
    Respirology; 2009 Nov; 14(8):1128-33. PubMed ID: 19909461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of 10 Candidate Biomarkers Distinguishing Tuberculous and Malignant Pleural Fluid by Proteomic Methods.
    Lee CY; Hong JY; Lee MG; Suh IB
    Yonsei Med J; 2017 Nov; 58(6):1144-1151. PubMed ID: 29047238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different expression of FoxM1 in human benign and malignant pleural effusion.
    Tang Z; Li H; Zhu H; Bai C
    Med Oncol; 2015 Jan; 32(1):312. PubMed ID: 25491139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.